ARDT · Ardent Health, Inc.

$10.61 +0.19 (+1.82%)

Market Cap

$1.49B

143.35M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$6.32B +6%

FY2025

Net Income

$135.81M -35.4%

FY2025

Diluted EPS

$0.96 -39.2%

FY2025

Operating Cash Flow

$470.51M +49.4%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022
Revenue	+7.2%	—	—	$6.4B – $6.7B	$6.43B	$6.32B	$5.97B	$5.41B	$5.13B
General & Administrative	+23.2%	—	—	—	$154.5M	$140.8M	$132.4M	$114.6M	$75.3M
Amortization of Intangibles	—	—	—	—	—	$800K	—	—	—
Depreciation & Amortization	+4.1%	—	—	—	—	$155.7M	$146.29M	$140.84M	$138.17M
Total Costs & Expenses	+7.8%	—	—	—	$6.14B	$6.04B	$5.6B	$5.26B	$4.82B
Pretax Income	-2.8%	—	—	—	$286.75M	$286.36M	$363.06M	$151.61M	$311.48M
Income Tax	+6.8%	—	—	—	$57.09M	$56.22M	$63.35M	$22.64M	$46.11M
Net Income	-10.4%	—	—	—	$134.28M	$135.81M	$210.34M	$53.9M	$188.91M
Net Margin	—	—	—	—	—	2.15%	3.53%	1%	3.68%
Net Income Attributable to Noncontrolling Interests	+7.2%	—	—	—	$95.38M	$94.32M	$89.37M	$75.07M	$76.46M
Comprehensive Income	-18.4%	—	—	—	$127.9M	$122.46M	$201.52M	$45.93M	$225.41M
EPS (Basic) USD/shares	-13.8%	—	—	—	—	$0.96	$1.59	$0.43	$1.50
EPS (Diluted) USD/shares	-13.8%	—	—	$0.90 – $1.27	—	$0.96	$1.58	$0.43	$1.50
Shares Outstanding (Basic Avg) shares	+3.7%	—	—	—	—	140.76M	132.44M	126.12M	126.12M
Shares Outstanding (Diluted Avg) shares	+3.9%	—	—	—	—	141.45M	132.74M	126.12M	126.12M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2024: $174.81M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

0.31×

Medical Care Facilities median 1.22×

EV/EBIT

—

Medical Care Facilities median 18.60×

P/E (TTM)

10.97×

Medical Care Facilities median 16.92×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022
Reportable Segment	$6,324,339,000	$5,966,072,000	$5,409,483,000	$5,129,687,000

Key facts CIK 1756655 CUSIP 03980N107 13F (30d) 15 filings 15 filers Visit website Investor relations